MetLife (NYSE:MET) Price Target Lowered to $86.00 at JPMorgan Chase & Co.

MetLife (NYSE:MET) had its price target reduced by equities research analysts at JPMorgan Chase & Co. from $88.00 to $86.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the financial services provider’s stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of 6.41% from the company’s previous close.

A number of other equities research analysts have also recently commented on MET. Morgan Stanley lifted their price target on shares of MetLife from $101.00 to $109.00 and gave the stock an “overweight” rating in a report on Friday, February 28th. Barclays lowered their target price on MetLife from $96.00 to $95.00 and set an “overweight” rating on the stock in a research note on Friday, February 7th. Wells Fargo & Company lifted their price objective on MetLife from $92.00 to $97.00 and gave the stock an “overweight” rating in a report on Wednesday, February 19th. Cowen reaffirmed a “buy” rating on shares of MetLife in a report on Friday, March 7th. Finally, Keefe, Bruyette & Woods reduced their target price on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a research note on Wednesday, February 12th. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.42.

MetLife Stock Down 0.4 %

MET stock opened at $80.82 on Wednesday. The stock has a market cap of $55.05 billion, a P/E ratio of 13.46, a P/E/G ratio of 0.65 and a beta of 1.04. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The stock’s fifty day simple moving average is $83.04 and its two-hundred day simple moving average is $83.01. MetLife has a 1-year low of $67.30 and a 1-year high of $89.05.

MetLife (NYSE:MET) last posted its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. Analysts expect that MetLife will post 9.65 EPS for the current year.

Institutional Investors Weigh In On MetLife

Several hedge funds have recently added to or reduced their stakes in MET. Neville Rodie & Shaw Inc. bought a new position in shares of MetLife during the 1st quarter valued at $225,000. Wealth Enhancement Advisory Services LLC raised its holdings in MetLife by 6.1% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 270,719 shares of the financial services provider’s stock valued at $22,166,000 after buying an additional 15,479 shares during the last quarter. Lansforsakringar Fondforvaltning AB publ bought a new stake in MetLife in the 4th quarter worth $16,359,000. Siemens Fonds Invest GmbH increased its position in shares of MetLife by 15.2% in the fourth quarter. Siemens Fonds Invest GmbH now owns 29,466 shares of the financial services provider’s stock valued at $2,413,000 after acquiring an additional 3,895 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of MetLife during the fourth quarter worth about $62,265,000. Institutional investors own 94.99% of the company’s stock.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.